University of East Anglia researchers make a breakthrough for ‘next gen’ cancer treatment

Read more

Lupin receives EIR from US FDA for its injectable facility in Nagpur

Read more

Glenmark gets second tentative ANDA approval for Saxagliptin Tablets, 2.5 mg and 5 mg

Read more

Moderna’s non-vaccine mRNA therapeutic can generate $278 million in 2028 if approved: GlobalData

Read more

GUERISON forays into India’s ophthalmology market

Read more

Herbalife Nutrition India forays into eye health segment with ocular defense

Read more

Asahi Kasei completes construction of second plant for Ceolus microcrystalline cellulose

Read more

AstraZeneca and DHS Jammu partners to bring down lung cancer burden

Read more

Lupin launches neuro-rehabilitation center in Mumbai

Read more

Biocon announces Q3FY23 results

Read more